KPV Peptide in Respiratory Research

Airway inflammation is a central theme in respiratory research, and KPV, a tiny melanocortin peptide, has become a compound of interest in laboratory models of asthma and allergic airway disease. This profile explains what KPV is, why it appears in respiratory work, and how to source consistent material in Canada.

What KPV is

KPV is a tripeptide built from lysine, proline, and valine. It is the C-terminal fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), a member of the melanocortin family. Laboratory studies suggest that much of the anti-inflammatory signalling attributed to alpha-MSH is preserved in this short fragment, which is why a three-residue peptide receives so much research attention.

Why respiratory researchers look at KPV

Allergic asthma models are, at their core, models of inflammation: immune cells infiltrate the airway, cytokines rise, and tissue responds. KPV enters this space for reasons that echo its use elsewhere in the body:

• Melanocortin anti-inflammatory signalling. The melanocortin pathway is broadly involved in dampening inflammatory responses, and KPV is examined as a minimal fragment that engages part of it.
• NF-kB modulation. As in gut and skin models, interest focuses on reduced NF-kB activity and the pro-inflammatory genes it controls.
• Cytokine and eosinophil readouts. Airway models often track eosinophil recruitment and cytokine levels, and researchers use KPV to observe how these markers shift.

This is model biology, not therapy. The value of KPV here is as a well-defined probe for asking questions about inflammatory signalling in airway tissue.

Delivery considerations

Respiratory research adds its own delivery puzzle. Getting a peptide to airway tissue in a controlled, reproducible way is a methods challenge, and labs explore formulations and delivery routes suited to the lung. As with gut research, a significant share of KPV work is really about how to present the molecule to the target tissue, not only what it does once it arrives.

A consistent thread across tissues

One reason KPV appears in skin, gut, and airway research alike is that inflammation shares machinery across these tissues. The NF-kB switch and the cytokines it controls are common to many inflammatory settings, so a fragment that engages the melanocortin anti-inflammatory pathway is relevant wherever that machinery is active. Respiratory work is, in this sense, one branch of a broader melanocortin-fragment literature. For researchers, that cross-tissue consistency is useful: methods and readouts developed in one model often translate, making KPV a convenient reference compound when moving between systems.

Stability and storage

KPV ships as a lyophilised powder and should be kept sealed, cool, dry, and out of direct light until a study needs it. Heat cycling, moisture, and prolonged light exposure are the main threats to peptide integrity, and careful storage keeps results comparable across experiments. A lot-specific certificate of analysis (COA) documents identity and purity for the exact material on your bench.

Choosing a supplier

Respiratory models are sensitive, and small differences in input material can muddy results. That makes characterisation and sourcing discipline important:

• Analytical verification by HPLC and mass spectrometry, with a COA per lot.
• A domestic supply chain that avoids uncontrolled transit conditions and long customs delays.

Sourcing KPV in Canada

LYFE Science is a Canadian supplier shipping across the country by Canada Post: flat $25, free over $150, neutral packaging, same-day dispatch on orders paid before noon ET, and 1 to 3 business days to most of Canada. Payment is by Interac e-Transfer or crypto (BTC, ETH, SOL, USDC, USDT), and every lot carries analytical documentation.

KPV is not yet part of the LYFE catalogue, but the range of research peptides is growing. See the peptide guide for how to interpret a COA, or contact us about availability.

Shop research peptides in Canada